Sharp Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	110	30	-	-
Enterprise Value	107	50	-	-
Last Close Price	3.65	1.05	1.05	-
PB Ratio	32.69	7.97	-	-
P/TBV Ratio	32.69	7.97	-	-
Debt / Equity Ratio	0.53	0.51	-1.10	-1.15
Quick Ratio	6.15	5.05	0.05	0.04
Current Ratio	6.32	5.10	0.06	0.05
Return on Assets (ROA)	-78.86%	-52.06%	-95.55%	-
Return on Capital (ROIC)	-103.58%	-63.32%	-124.33%	-
Earnings Yield	-3.64%	-15.83%	-	-
FCF Yield	-	-17.63%	-	-
Buyback Yield / Dilution	-438.65%	-107.12%	-3028.62%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.